Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
315
-
Total 13F shares, excl. options
-
75,251,763
-
Shares change
-
+1,392,504
-
Total reported value, excl. options
-
$9,945,540,551
-
Value change
-
+$137,940,262
-
Put/Call ratio
-
32.11%
-
Number of buys
-
134
-
Number of sells
-
-187
-
Price
-
$132.18
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2021
410 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2021.
NovoCure Ltd - Common Stock (NVCR) has 315 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75,251,763 shares
of 111,111,111 outstanding shares and own 67.73% of the company stock.
Largest 10 shareholders include Capital International Investors (9,117,624 shares), FMR LLC (9,088,438 shares), BAILLIE GIFFORD & CO (8,863,932 shares), Capital World Investors (8,637,523 shares), VANGUARD GROUP INC (8,396,783 shares), BlackRock Inc. (6,424,960 shares), STATE STREET CORP (2,047,896 shares), CREDIT SUISSE AG/ (1,632,847 shares), MORGAN STANLEY (1,234,928 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1,227,702 shares).
This table shows the top 315 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.